375.43
price down icon0.41%   -1.54
after-market Handel nachbörslich: 374.00 -1.43 -0.38%
loading
Schlusskurs vom Vortag:
$376.97
Offen:
$376.17
24-Stunden-Volumen:
2.28M
Relative Volume:
0.81
Marktkapitalisierung:
$202.38B
Einnahmen:
$36.74B
Nettoeinkommen (Verlust:
$7.71B
KGV:
26.38
EPS:
14.2333
Netto-Cashflow:
$8.10B
1W Leistung:
-0.42%
1M Leistung:
+2.96%
6M Leistung:
+34.80%
1J Leistung:
+14.68%
1-Tages-Spanne:
Value
$372.74
$379.26
1-Wochen-Bereich:
Value
$361.39
$380.09
52-Wochen-Spanne:
Value
$261.43
$391.29

Amgen Inc Stock (AMGN) Company Profile

Name
Firmenname
Amgen Inc
Name
Telefon
(805)447-1000
Name
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Name
Mitarbeiter
31,500
Name
Twitter
@amgen
Name
Nächster Verdiensttermin
2026-02-03
Name
Neueste SEC-Einreichungen
Name
AMGN's Discussions on Twitter

Compare AMGN vs LLY, JNJ, ABBV, NVS, AZN

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
AMGN
Amgen Inc
375.43 203.21B 36.74B 7.71B 8.10B 14.23
Drug Manufacturers - General icon
LLY
Lilly Eli Co
1,001.35 900.48B 65.18B 20.64B 5.96B 22.59
Drug Manufacturers - General icon
JNJ
Johnson Johnson
243.71 584.62B 94.19B 26.80B 19.70B 11.05
Drug Manufacturers - General icon
ABBV
Abbvie Inc
227.01 402.17B 61.16B 4.19B 17.82B 2.3614
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
161.59 310.63B 54.72B 14.02B 15.32B 7.1855
Drug Manufacturers - General icon
AZN
Astrazeneca Plc
194.99 302.33B 58.80B 10.24B 8.98B 3.2788

Amgen Inc Stock (AMGN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-02-20 Eingeleitet Barclays Equal Weight
2026-01-20 Herabstufung Bernstein Outperform → Mkt Perform
2026-01-07 Fortgesetzt UBS Buy
2025-12-05 Hochstufung Erste Group Hold → Buy
2025-11-24 Fortgesetzt Truist Hold
2025-11-13 Eingeleitet Scotiabank Sector Outperform
2025-09-03 Fortgesetzt Raymond James Mkt Perform
2025-05-20 Fortgesetzt Guggenheim Neutral
2025-04-22 Fortgesetzt Cantor Fitzgerald Neutral
2024-12-10 Fortgesetzt BofA Securities Underperform
2024-11-15 Eingeleitet Wolfe Research Peer Perform
2024-11-14 Eingeleitet Citigroup Neutral
2024-10-17 Eingeleitet Bernstein Outperform
2024-10-14 Herabstufung Truist Buy → Hold
2024-09-27 Eingeleitet Cantor Fitzgerald Overweight
2024-08-07 Herabstufung Wells Fargo Overweight → Equal Weight
2024-05-03 Hochstufung Barclays Underweight → Equal Weight
2024-05-03 Hochstufung William Blair Mkt Perform → Outperform
2024-03-28 Fortgesetzt Raymond James Mkt Perform
2024-02-07 Herabstufung Leerink Partners Outperform → Market Perform
2023-12-21 Hochstufung Daiwa Securities Neutral → Buy
2023-12-19 Hochstufung BMO Capital Markets Market Perform → Outperform
2023-12-12 Hochstufung RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Eingeleitet Deutsche Bank Hold
2023-11-02 Hochstufung Truist Hold → Buy
2023-10-20 Fortgesetzt JP Morgan Neutral
2023-10-17 Fortgesetzt Morgan Stanley Equal-Weight
2023-10-11 Fortgesetzt BofA Securities Neutral
2023-09-06 Eingeleitet HSBC Securities Buy
2023-04-24 Bestätigt Oppenheimer Outperform
2023-03-13 Hochstufung Wells Fargo Equal Weight → Overweight
2023-02-13 Bestätigt Truist Buy
2022-11-18 Eingeleitet Credit Suisse Underperform
2022-10-31 Herabstufung Barclays Equal Weight → Underweight
2022-10-11 Hochstufung Morgan Stanley Equal-Weight → Overweight
2022-05-23 Eingeleitet SVB Leerink Mkt Perform
2022-02-09 Bestätigt Barclays Equal Weight
2022-02-09 Bestätigt Jefferies Buy
2022-02-09 Bestätigt Morgan Stanley Equal-Weight
2022-02-09 Bestätigt Oppenheimer Outperform
2022-02-09 Bestätigt Wells Fargo Equal Weight
2022-01-05 Herabstufung BofA Securities Buy → Neutral
2021-12-09 Fortgesetzt Wells Fargo Equal Weight
2021-12-06 Eingeleitet Goldman Buy
2021-11-19 Eingeleitet BMO Capital Markets Market Perform
2021-09-23 Herabstufung Daiwa Securities Outperform → Neutral
2021-09-07 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-12-29 Eingeleitet Daiwa Securities Buy
2020-10-28 Eingeleitet UBS Neutral
2020-10-26 Hochstufung Raymond James Mkt Perform → Outperform
2020-10-12 Hochstufung Truist Hold → Buy
2020-10-09 Herabstufung Bernstein Outperform → Mkt Perform
2020-10-09 Herabstufung Truist Buy → Hold
2020-10-08 Herabstufung Raymond James Outperform → Mkt Perform
2020-04-15 Fortgesetzt Guggenheim Neutral
2020-03-31 Eingeleitet Wolfe Research Peer Perform
2020-03-30 Hochstufung Raymond James Mkt Perform → Outperform
2020-03-05 Hochstufung BofA/Merrill Neutral → Buy
2020-02-27 Eingeleitet Barclays Equal Weight
2020-01-31 Herabstufung Robert W. Baird Neutral → Underperform
2020-01-21 Hochstufung Evercore ISI In-line → Outperform
2019-12-24 Eingeleitet Raymond James Mkt Perform
2019-12-17 Fortgesetzt Morgan Stanley Overweight
2019-11-12 Eingeleitet SunTrust Buy
2019-11-05 Hochstufung Cantor Fitzgerald Neutral → Overweight
2019-10-17 Fortgesetzt BofA/Merrill Neutral
2019-08-19 Herabstufung Mizuho Buy → Neutral
2019-05-23 Hochstufung Citigroup Neutral → Buy
Alle ansehen

Amgen Inc Aktie (AMGN) Neueste Nachrichten

pulisher
03:12 AM

Crysvita Market Is Going to Boom | Kyowa Kirin • Amgen • Sanofi • Takeda Pharmaceutical - openPR.com

03:12 AM
pulisher
02:08 AM

Rep. David Taylor Sells Off Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat

02:08 AM
pulisher
Mar 09, 2026

SNL mocks Amgen’s Otezla in bizarre sketch featuring Ryan Gosling - Medical Marketing and Media

Mar 09, 2026
pulisher
Mar 09, 2026

Amgen Named to Forbes’ 2026 List of America’s Best Large Employers - Amgen

Mar 09, 2026
pulisher
Mar 09, 2026

9 Health Care Stocks With Whale Alerts In Today's Session - Benzinga

Mar 09, 2026
pulisher
Mar 09, 2026

Take the Zacks Approach to Beat the Markets: Starbucks, Amgen, Allogene in Focus - TradingView

Mar 09, 2026
pulisher
Mar 09, 2026

Swiss National Bank Sells 77,600 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 09, 2026
pulisher
Mar 09, 2026

The first KRAS drugs have been sluggish on the market. Will the next generation fare better? - Pharma Voice

Mar 09, 2026
pulisher
Mar 09, 2026

Therapeutics Companies Exceed Q4 2025 Revenue Estimates, Led by Novavax and AmgenNews and Statistics - IndexBox

Mar 09, 2026
pulisher
Mar 09, 2026

Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks - Finviz

Mar 09, 2026
pulisher
Mar 09, 2026

First Trust Advisors LP Sells 46,048 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 09, 2026
pulisher
Mar 08, 2026

Better Weight Loss Stock: Novo Nordisk Vs. Amgen - The Globe and Mail

Mar 08, 2026
pulisher
Mar 08, 2026

Better Weight Loss Stock: Novo Nordisk Vs. Amgen - The Motley Fool

Mar 08, 2026
pulisher
Mar 08, 2026

Amgen Inc. (AMGN) Completes Phase 3 Trial for ABP 206 Opdivo Biosimilar Candidate - Yahoo Finance

Mar 08, 2026
pulisher
Mar 08, 2026

Vinva Investment Management Ltd Increases Holdings in Amgen Inc. $AMGN - MarketBeat

Mar 08, 2026
pulisher
Mar 08, 2026

Korea Investment CORP Sells 22,072 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 08, 2026
pulisher
Mar 08, 2026

Blair William & Co. IL Reduces Position in Amgen Inc. $AMGN - MarketBeat

Mar 08, 2026
pulisher
Mar 08, 2026

B. Metzler seel. Sohn & Co. AG Has $14.48 Million Stake in Amgen Inc. $AMGN - MarketBeat

Mar 08, 2026
pulisher
Mar 07, 2026

Assessing Amgen (AMGN) Valuation After Rocatinlimab Trial Halt And Pipeline Setback - simplywall.st

Mar 07, 2026
pulisher
Mar 07, 2026

56,522 Shares in Amgen Inc. $AMGN Bought by Munich Reinsurance Co Stock Corp in Munich - MarketBeat

Mar 07, 2026
pulisher
Mar 07, 2026

Neuberger Berman Group LLC Sells 3,315 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 07, 2026
pulisher
Mar 07, 2026

Amgen Inc. (NASDAQ:AMGN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Mar 07, 2026
pulisher
Mar 06, 2026

3,603 Shares in Amgen Inc. $AMGN Purchased by Integrity Advisory Solutions LLC - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Pitcairn Co. Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Wearable Injectors Market Set to Witness Rapid Growth Through - openPR.com

Mar 06, 2026
pulisher
Mar 06, 2026

Edgar Lomax Co. VA Sells 29,960 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

American Century Companies Inc. Raises Stock Holdings in Amgen Inc. $AMGN - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Xgeva Market Booming with Rapid Growth Through 2033 | Amgen • Novartis • Pfizer • Eli Lilly - openPR.com

Mar 06, 2026
pulisher
Mar 05, 2026

AMGEN TO PRESENT AT THE LEERINK PARTNERS 2026 GLOBAL HEALTHCARE CONFERENCE - Amgen

Mar 05, 2026
pulisher
Mar 05, 2026

Kyowa Kirin discontinues rocatinlimab trials due to safety issues - bioworld.com

Mar 05, 2026
pulisher
Mar 05, 2026

Amgen Faces Rocatinlimab Halt And Rethinks Pipeline And Capital Priorities - Yahoo Finance

Mar 05, 2026
pulisher
Mar 05, 2026

Why Is Amgen (AMGN) Up 3.6% Since Last Earnings Report? - Yahoo Finance

Mar 05, 2026
pulisher
Mar 05, 2026

Amgen Inc Stock (AMGN) Moved Down by 3.08% on Mar 5: Key Drivers Unveiled - TradingKey

Mar 05, 2026
pulisher
Mar 05, 2026

Amgen Inc. (NASDAQ:AMGN) Plans Quarterly Dividend of $2.52 - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Amgen: Wait For A Better Entry Point (Rating Downgrade) (NASDAQ:AMGN) - Seeking Alpha

Mar 05, 2026
pulisher
Mar 05, 2026

ARK Investment Management LLC Sells 10,668 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

CI Investments Inc. Has $6.34 Million Stock Position in Amgen Inc. $AMGN - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Rocatinlimab Halt Puts Spotlight On Amgen Pipeline Mix And Valuation Gap - simplywall.st

Mar 05, 2026
pulisher
Mar 04, 2026

Is Amgen (AMGN) Pricing Reflect Its Recent 24% One Year Share Price Return - Yahoo Finance

Mar 04, 2026
pulisher
Mar 04, 2026

Amgen (AMGN) Maintains Quarterly Dividend of $2.52 Per Share - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Amgen Keeps Quarterly Dividend at $2.52 a Share, Payable June 5 to Holders of Record May 15 - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

AMGEN ANNOUNCES 2026 SECOND QUARTER DIVIDEND - Amgen

Mar 04, 2026
pulisher
Mar 04, 2026

Amgen announces 2026 second quarter dividend - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

Amgen Advances Blinatumomab Franchise With New Phase 3 Subcutaneous Trial - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

Dimensional Fund Advisors Boosts Amgen Holdings - National Today

Mar 04, 2026
pulisher
Mar 04, 2026

Smith Chas P & Associates PA Cpas Sells 47,455 Shares of Amgen Inc. $AMGN - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Amgen Inc. $AMGN Shares Sold by Victory Capital Management Inc. - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Mcdonald Partners LLC Decreases Holdings in Amgen Inc. $AMGN - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - GlobeNewswire Inc.

Mar 04, 2026
pulisher
Mar 04, 2026

Dimensional Fund Advisors LP Raises Holdings in Amgen Inc. $AMGN - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Is It Time To Reassess Amgen (AMGN) After Its Strong Multi Year Share Price Run? - simplywall.st

Mar 04, 2026

Finanzdaten der Amgen Inc-Aktie (AMGN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$148.56
price up icon 1.32%
drug_manufacturers_general NVO
$38.72
price down icon 2.66%
drug_manufacturers_general PFE
$27.16
price up icon 1.31%
drug_manufacturers_general MRK
$117.09
price down icon 0.02%
drug_manufacturers_general AZN
$194.99
price up icon 0.02%
Kapitalisierung:     |  Volumen (24h):